Cargando…
Development and optimization of targeted radionuclide tumor therapy using folate based radiopharmaceuticals
The folate receptor (FR) has been used for a quarter of a century as a tumor-associated target for selective delivery of drugs and imaging agents to cancer cells. While several folic acid radioconjugates have been successfully employed for imaging purposes in (pre)clinical studies, a therapeutic app...
| Autor principal: | |
|---|---|
| Lenguaje: | eng |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | http://cds.cern.ch/record/2063482 |